Xu YG - Search Results

1

Discovery of cyanoguanidine derivatives as biased μ-opioid receptor agonists.

Zhu LH, Mao HH, He M, Cui ZY, Zhu QH, Gu HF, Xu YG. Zhu LH, et al. Among authors: xu yg. Bioorg Med Chem. 2024 Nov 15;114:117943. doi: 10.1016/j.bmc.2024.117943. Epub 2024 Oct 16. Bioorg Med Chem. 2024. PMID: 39442489

2

Design, synthesis and biological evaluation of novel substituted benzoylguanidine derivatives as potent Na+/H+ exchanger inhibitors.

Xu WT, Jin N, Xu J, Xu YG, Wang QJ, You QD. Xu WT, et al. Among authors: xu yg, xu j. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3283-7. doi: 10.1016/j.bmcl.2009.04.079. Epub 2009 Apr 23. Bioorg Med Chem Lett. 2009. PMID: 19433354

3

Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors.

Zhu Q, Wang X, Chu Z, He G, Dong G, Xu Y. Zhu Q, et al. Bioorg Med Chem Lett. 2013 Apr 1;23(7):1993-6. doi: 10.1016/j.bmcl.2013.02.032. Epub 2013 Feb 16. Bioorg Med Chem Lett. 2013. PMID: 23481647

4

Synthesis and pharmacological evaluation of novel limonin derivatives as anti-inflammatory and analgesic agents with high water solubility.

Yang Y, Wang X, Zhu Q, Gong G, Luo D, Jiang A, Yang L, Xu Y. Yang Y, et al. Bioorg Med Chem Lett. 2014 Apr 1;24(7):1851-5. doi: 10.1016/j.bmcl.2014.02.003. Epub 2014 Feb 10. Bioorg Med Chem Lett. 2014. PMID: 24569111

5

Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.

Shi L, Wu TT, Wang Z, Xue JY, Xu YG. Shi L, et al. Among authors: xu yg. Eur J Med Chem. 2014 Sep 12;84:698-707. doi: 10.1016/j.ejmech.2014.07.071. Epub 2014 Jul 21. Eur J Med Chem. 2014. PMID: 25064347

6

Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2.

Shi L, Wu TT, Wang Z, Xue JY, Xu YG. Shi L, et al. Among authors: xu yg. Bioorg Med Chem. 2014 Sep 1;22(17):4735-44. doi: 10.1016/j.bmc.2014.07.008. Epub 2014 Jul 11. Bioorg Med Chem. 2014. PMID: 25082515

7

p-Toluenesulfonohydrazide as highly efficient initiator for direct C-H arylation of unactivated arenes.

Song Q, Zhang D, Zhu Q, Xu Y. Song Q, et al. Org Lett. 2014 Oct 17;16(20):5272-4. doi: 10.1021/ol502370r. Epub 2014 Sep 29. Org Lett. 2014. PMID: 25264812

8

Design, Synthesis, and Biological Evaluation of Dabigatran Etexilate Mimics, a Novel Class of Thrombin Inhibitors.

Wang S, Dai P, Xu Y, Chen Q, Zhu Q, Gong G. Wang S, et al. Arch Pharm (Weinheim). 2015 Aug;348(8):595-605. doi: 10.1002/ardp.201500101. Epub 2015 Jun 29. Arch Pharm (Weinheim). 2015. PMID: 26120827

9

Efficient Palladium-Catalyzed C-H Fluorination of C(sp3)-H Bonds: Synthesis of β-Fluorinated Carboxylic Acids.

Zhu Q, Ji D, Liang T, Wang X, Xu Y. Zhu Q, et al. Org Lett. 2015 Aug 7;17(15):3798-801. doi: 10.1021/acs.orglett.5b01774. Epub 2015 Jul 14. Org Lett. 2015. PMID: 26172446

10

Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer.

Zhu Q, Wang X, Hu Y, He X, Gong G, Xu Y. Zhu Q, et al. Bioorg Med Chem. 2015 Oct 15;23(20):6551-9. doi: 10.1016/j.bmc.2015.09.026. Epub 2015 Sep 16. Bioorg Med Chem. 2015. PMID: 26422786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters